PharmaVOICE - 
June 2020
Purchase Issue
In Every Issue
Letter from the Editor
Raising the bar … Last month, I noted that the [...]
By

Taren Grom, Editor

Upfront
Interest in Clinical Trials Increases Amid Pandemic According to a [...]
By

PharmaVOICE Staff

HealthTech
Apple and Google Partner on COVID-19 Contact Tracing Technology Trend [...]
By

PharmaVOICE Staff

Artificial Intelligence
BenevolentAI Uncovers Potential Coronavirus Treatment, Enters Phase III Trials Trend [...]
By

PharmaVOICE Staff

Last Word
Getting Into the Biology of Prostate Cancer Dr. Margaret Yu, [...]
By

Dr. Margaret Yu, VP, Disease Area Leader Prostate Cancer, Janssen Research and Development

On The Cover

A New Era of Clinical Trials
The future is now, and how the industry responds to the COVID-19 pandemic will set the course for drug development for years to come. The COVID-19 pandemic has created disruption across every aspect of the world. The clinical trial ecosystem is no exception — from drug discovery through to regulatory approval — processes, drug development [...]
By

Taren Grom, Editor

Features

SHOWCASE: Clinical Trial Solutions: Improving Trials with Technology
Technology is taking center stage as a way to mitigate clinical challenges and improve patient outcomes. The clinical trials market is massive and continues to grow. According to a report from Grand View Research, the global clinical trials market will be worth .2 billion by 2025. At the same time, clinical trials are costly, with [...]
By

PharmaVOICE Staff

Effective Design and Implementation of Sponsor/CRO Governance — Reducing Risk While Enhancing Transparency
Governance board meetings have always been an important venue to ensure quality and maintain a healthy and productive relationship between sponsors and CROs. As the demands of the clinical research industry continue to evolve with a pandemic now amongst us, the need for effective program governance is more important than ever. Like any good governance [...]
By

Melissa Mauriber, VP, Clinical Operations Quality and Talent Development, Advanced Clinical

Virtual Trials: The Silver Lining of the COVID-19 Pandemic
Many of us are identifying the proverbial silver linings associated with the changes we have been forced to make in response to the COVID-19 pandemic. One rather sweeping silver lining is the increased and accelerated use of technology in both our business and personal lives, with an obvious example being the now pervasive use of [...]
By

Jim Mahon, VP, Chief Strategy and Marketing Officer, ERT

How COVID-19 Changed the Way We Recruit
Amplifying the need for a new era of strategic patient recruitment and retention. The need for rapid and adaptive recruiting strategies has never been more urgent than in response to COVID-19. This pandemic is pushing those working to develop new treatments to pursue more agile and innovative strategies to accelerate recruiting for clinical trials while [...]
By

Erica Prowisor, Global Head, Recruitment & Retention, IQVIA

Real-World Data for R&D
Developing a much-needed new therapeutic, maybe even for Covid 19? Seeking approval to expand labeling for an existing treatment? Wanting to understand the standard of care, design a trial, create a comparator cohort, identify a new biomarker, or model patients most likely to benefit from a particular therapy? From drug development to personalized treatment, high-quality, [...]
By

Richard Gilklich, M.D., CEO, OM1

Leveraging Remote Monitoring to Increase Safety, Results and Efficiencies During the Pandemic and Beyond
In 2020, the phrase “clinical trial solutions” takes on a new — and more relevant — meaning than ever before. The world needs a solution to the global COVID-19 pandemic, and we in the life-sciences industry can contribute to that solution through innovative, state-of-the-art technology that enables clinical trials to not only proceed, but flourish [...]
By

Gergory T. Simpson, VP and Head of Marketing, Saama Technologies

Behavioral Science in Marketing
It takes more than knowledge to drive behavior change; it takes understanding people’s motivations and providing the tools or skills needed to influence actions. Many of us have been forced to change our normal behaviors and activities during COVID-19. In order to practice prevention protocols that keep ourselves and those we love safe from the [...]
By

Robin Robinson

Age of the Machine: Using Algorithms to Advance Outcomes
Machine learning is being applied across the industry to support decision-making in clinical trials, R&D, regulatory, and commercial processes. What’s the difference between machine learning and artificial intelligence? The answer lies in the word intelligence, since AI is about enabling machines to make decisions, whereas machine learning refers to the ability to teach machines to [...]
By

Kim Ribbink

Commanders & Chiefs: Chief Creative Officers
The role of the agency chief creative officer today requires a unique balance of artistry, science, and channel expertise. Steve Hamburg The Art of the Design Successful creative must deliver surprise, delight, excitement, and awe. It must show us the world in a new way. It must memorably engage the mind and excite the heart. [...]
By

PharmaVOICE Staff

Speak Out: The Increased Spotlight on Digital CME
In 2009, the American College of Chest Physicians published an article in CHEST that explored the future of continuing medical education (CME) and focused on the impact of technology on physician learning, including on the importance of digital CME. Now, in 2020, digital CME has evolved to include a variety of innovative formats and platforms, [...]
By

Christina Hoffman, MS, Group Vice President, Quality & Strategy, Medscape Education

Executive Perspective: Transforming the Clinical Experience As a Digital Care Option for Patients — A New Age of Care
A Conversation with MaryAnne Rizk, Ph.D. For MaryAnne Rizk, Ph.D., Senior VP, Digital R&D Strategy at IQVIA, improving the patient experience is more than a calling; it’s a passion. She is driven by an inherent desire to improve the quality of life for patients. Her particular area of expertise is creating innovative technology solutions to [...]
By

Mary Ann Rizk, Ph.D., Senior VP, Digital R&D Strategy, IQVIA

FEEDBACK